Expanded Access to RGX-202

Part of paid clinical trials in Rockville, Maryland.

Sponsor
REGENXBIO Inc.
Study ID
NCT07652606
Status
Temporarily Not Available

Eligibility Criteria

Sex
All
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • RGX-202 — GENETIC

Study Details

Provide single patient expanded access to RGX-202 for eligible patients

Key Dates

Status verified
Jun 2026

Locations (1)

FacilityCityStateZIPSite coordinators
RegenxbioRockvilleMaryland20850-

Find similar trials in Rockville, MD